Form 4: EXACT SCIENCES EVP Granted 23,224 Restricted Stock Units

Exact Sciences' EVP of Human Resources, Sarah Condella, was granted 23,224 restricted stock units, vesting over four years.

Summary

• Sarah Condella, Executive Vice President of Human Resources at EXACT SCIENCES CORP (EXAS), reported a transaction on February 25, 2026.
• Condella was granted 23,224 Restricted Stock Units (RSUs).
• Each RSU represents a contingent right to receive one share of common stock.
• These RSUs will vest in four equal annual installments, commencing on February 25, 2027.
• Following this transaction, Condella directly holds 129,134 shares of Common Stock.
• Condella also indirectly holds 6,355 shares of Common Stock in a 401(k) Plan.
• In aggregate, Condella beneficially owns 135,489 shares of Common Stock reported on this Form 4.
• Additionally, Condella holds 75,143 vested and unvested options to purchase shares of Common Stock and other restricted stock units not detailed in this specific transaction.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive, routine executive compensation event. It reflects ongoing efforts to align executive incentives with long-term company performance, which is generally favorable for corporate governance and stability.

Positives

• The grant of 23,224 Restricted Stock Units (RSUs) to a key executive aligns management's long-term interests with shareholder value.
• The vesting schedule over four years promotes executive retention and sustained performance.

Future Outlook

The Restricted Stock Units are scheduled to vest in four equal annual installments beginning on February 25, 2027, indicating a future incentive structure for the executive.

Industry Context

StockSavvy.ai notes that the grant of Restricted Stock Units (RSUs) is a standard practice in executive compensation across various industries, including healthcare and diagnostics. This method is widely used to incentivize long-term performance and align executive interests with the company's strategic goals and shareholder returns.

Stakeholder Impact

• Shareholders: The RSU grant aligns the executive's financial interests with the long-term performance of the company, potentially benefiting shareholders through sustained growth and value creation.
• Employees: This transaction is specific to executive compensation and does not directly impact the broader employee base, though it reflects the company's overall compensation philosophy.

Next Steps

• The Restricted Stock Units will vest in four equal annual installments, with the first installment occurring on February 25, 2027.

Key Dates

Recommendation

This Form 4 reports a routine grant of restricted stock units to an executive, which is a standard component of executive compensation. It does not provide new information that would fundamentally alter the investment thesis for Exact Sciences, hence a 'hold' recommendation is maintained. Investors should consider broader company fundamentals and market conditions for investment decisions.

Keywords

EXACT SCIENCES, EXAS, Form 4, Insider Transaction, Restricted Stock Units, RSU Grant, Executive Compensation, Sarah Condella